Disclosures: Ahmad Anouti: Nothing to Disclose, Hamza Dahshi: Nothing to Disclose, Thomas Cotter: Nothing to Disclose, Christine Hwang: Nothing to Disclose, Timucin Taner: Nothing to Disclose, Julie Heimbach: Nothing to Disclose, Madhukar Patel: Nothing to Disclose, William Lee: Nothing to Disclose, Sara Hassan: Nothing to Disclose 1338 PREDICTING LIVER GRAFT DISCARD CRITERIA: A MACHINE LEARNING APPROACH TO KEY DONOR CHARACTERISTICS Ahmad Anouti 1 Hamza Dahshi 2 Thomas Cotter 1 Samar Ibrahim 3 William Lee 1 Timucin Taner 3 Julie Heimbach 3 Madhukar Patel 1 Sara Hassan 3 , 1 UT Southwestern Medical Center, 2 Case Western School of Medicine, 3 Mayo Clinic Rochester Background: One of the primary challenges in liver transplantation is the shortage of available donor organs
If you dont have a GP, several online telemedicine websites now offer GLP-1 agonists for weight loss
Futures Forward Research Institute, Toms River, New Jersey (Goodwin, Brancaccio, Mossolem)
PlexusDx Weight Management Protocols use compounded semaglutide and tirzepatide from licensed U.S
In a recently completed phase 2 trial (abstract data), 46 weeks of survodutide once weekly (0.6 to 4.8 mg) resulted in a dose-dependent mean WL up to 18.7% vs
